BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 1085288)

  • 21. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J; Stiller RA
    J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of murine leukemia virus in bone marrow-derived lymphocytes.
    Ruddle NH; Armstrong MK; Richards FF
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3714-8. PubMed ID: 185625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.
    Hankins WD; Krantz SB
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5287-91. PubMed ID: 6933561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
    Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
    J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
    Brightman BK; Li QX; Trepp DJ; Fan H
    J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B and T lymphocyte activation by murine leukemia virus infection.
    Bendinelli M; Friedman H
    Adv Exp Med Biol; 1979; 121B():91-7. PubMed ID: 317564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
    Isaak DD; Price JA; Reinisch CL; Cerny J
    J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
    [No Abstract]   [Full Text] [Related]  

  • 29. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of natural killer cell activity by Friend murine leukemia virus.
    Moody DJ; Specter S; Bendinelli M; Friedman H
    J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
    Schultz KR; Klarnet JP; Gieni RS; HayGlass KT; Greenberg PD
    Science; 1990 Aug; 249(4971):921-3. PubMed ID: 2118273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA; Green WR; Rich RF
    Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of T- and B-lymphocyte mitogens on interactions between lymphocytes and macrophages.
    Stoecker CA; Rickard BM; Abel CA
    Cell Immunol; 1978 Feb; 35(2):362-77. PubMed ID: 304382
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.
    Miyazawa M; Nishio J; Chesebro B
    J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of glutamine on murine splenic leukocyte responses to T and B cell mitogens.
    Griffiths M; Keast D
    Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():405-8. PubMed ID: 2097296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
    Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextran-triggered T cells heighten T- and B-cell reactions to mitogens.
    Alevy YG; Battisto JR
    Immunology; 1976 Mar; 30(3):379-90. PubMed ID: 1082852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of interleukin 2 on enhancement of concanavalin A-induced human peripheral blood lymphocyte proliferation by murine B cell mitogens.
    Nitta T; Konno-Ejiri H; Okumura S; Ozawa A; Nakano M
    Microbiol Immunol; 1985; 29(5):441-9. PubMed ID: 3875780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.